27 studies found for:    " February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (27 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Computer Assisted Rx Education for HIV-Positives: CARE+
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: CARE+
2 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
3 Completed
Has Results
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
4 Unknown  Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Intervention: Behavioral: Prevention Care Advocate
5 Active, not recruiting A Phase 2 Study of the Safety of Ritonavir-Boosted Elvitegravir Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Elvitegravir;   Drug: Ritonavir;   Drug: ARV regimen
6 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
7 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
8 Completed Positive Choice: Prevention for Positive Health
Conditions: HIV Infections;   Sexual Risk Behavior;   Substance Use Risks
Intervention: Behavioral: Positive Choice
9 Completed HIV Prevention Among Substance Abusing SMI
Conditions: Mentally Ill Persons;   Substance Abuse;   HIV Infections
Intervention: Behavioral: PATH
10 Completed Enhancing Oral Health Care Use by HIV Positive Individuals
Conditions: Oral Health Care;   HIV Infections;   Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention
11 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
12 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
13 Completed Trial of Zinc and HIV Progression in Children
Condition: HIV Infections
Intervention: Dietary Supplement: Zinc
14 Completed
Has Results
Pioglitazone to Treat Fatty Liver in People With HIV Infection
Conditions: HIV Infections;   Hepatic Steatosis;   Insulin Resistance
Intervention: Drug: Pioglitazone
15 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo
16 Completed Safety Study of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: Placebo gel;   Drug: UC 781
17 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
18 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
19 Terminated
Has Results
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
20 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years